CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,720 | -42.3% | 91,642 | +1.1% | 0.00% | 0.0% |
Q2 2023 | $108,770 | +1.1% | 90,642 | -1.4% | 0.00% | 0.0% |
Q1 2023 | $107,543 | +45.3% | 91,917 | -1.9% | 0.00% | 0.0% |
Q4 2022 | $74,036 | -99.9% | 93,717 | -46.9% | 0.00% | 0.0% |
Q3 2022 | $107,107,000 | +164680.0% | 176,344 | +148.0% | 0.00% | 0.0% |
Q2 2022 | $65,000 | -9.7% | 71,102 | +77.1% | 0.00% | 0.0% |
Q1 2022 | $72,000 | +7.5% | 40,137 | -7.2% | 0.00% | 0.0% |
Q4 2021 | $67,000 | -19.3% | 43,237 | +5.6% | 0.00% | 0.0% |
Q3 2021 | $83,000 | – | 40,958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
Freed Investment Group | 14,600 | $26,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
LMR Partners LLP | 63,950 | $114,000 | 0.00% |
Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |